Covered recipient · General Payments record
JONATHAN LEROY GANDY
Eye and Vision Services Providers Optometrist
General Payments · PY2018–2024
$1,573.12
- Reported across 52 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $569.77 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $248.01 | 8 |
| Bausch & Lomb Americas Inc. | $131.23 | 2 |
| GLAUKOS CORPORATION | $70.01 | 1 |
| ABBVIE INC. | $60.99 | 3 |
| Dompe US, Inc. | $26.12 | 1 |
| Tarsus Pharmaceuticals, Inc. | $16.79 | 1 |
| Thea Pharma Inc. | $16.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.55 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103770658 | CMS |
| ABBVIE INC. | $16.56 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103770660 | CMS |
| ABBVIE INC. | $23.88 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103770662 | CMS |
| Alcon Vision LLC | $1.54 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110698349 | CMS |
| Alcon Vision LLC | $8.41 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110698351 | CMS |
| Alcon Vision LLC | $22.08 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110698357 | CMS |
| Alcon Vision LLC | $14.89 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110698353 | CMS |
| Alcon Vision LLC | $29.90 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110699504 | CMS |
| Alcon Vision LLC | $119.00 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110699508 | CMS |
| Alcon Vision LLC | $15.55 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110698355 | CMS |
| Alcon Vision LLC | $36.64 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110699506 | CMS |
| Bausch & Lomb Americas Inc. | $124.99 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140374573 | CMS |
| Bausch & Lomb Americas Inc. | $6.24 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140374571 | CMS |
| Dompe US, Inc. | $26.12 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151407059 | CMS |
| Glaukos Corporation | $70.01 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151984662 | CMS |
| Tarsus Pharmaceuticals, Inc. | $16.79 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139097827 | CMS |
| Thea Pharma Inc. | $16.62 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074541009 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.